A Pharmacogenetic Trial of Tacrolimus Dosing After Pediatric Transplantation
Phase of Trial: Phase II
Latest Information Update: 25 Aug 2016
At a glance
- Drugs Tacrolimus (Primary)
- Indications Transplant rejection
- Focus Pharmacogenomic; Pharmacokinetics
- 18 Aug 2016 Status changed from discontinued to completed.
- 25 Feb 2016 Status changed from recruiting to discontinued, according to ClinicalTrials.gov record.
- 30 Sep 2015 Planned number of patients changed from 60 to 95 as reported by ClinicalTrials.gov record.